Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Batch Consistency of EV71 Vaccine in Infants
NCT07026500Phase 4Completed
- Sponsor
- Sinovac Biotech Ltd.
- Start
- Sep 2019
- Primary completion
- Apr 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of enterovirus 71 vaccine (vero cell), inactivated in HIV-associated central nervous system involvement (HAND), sponsored by Sinovac Biotech Ltd.. Started Sep 2019; status: completed.
02
Drugs
enterovirus 71 vaccine (vero cell), inactivated
03
Conditions
HIV-associated central nervous system involvement (HAND)
Beyond the preview
Go deeper on NCT07026500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07026500.